Next Article in Journal
The Effect of Composition, Pre-Treatment on the Mechanical and Acoustic Properties of Apple Gels and Freeze-Dried Materials
Previous Article in Journal
Nasal Delivery of Cinnarizine Thermo- and Ion-Sensitive In Situ Hydrogels for Treatment of Microwave-Induced Brain Injury
Previous Article in Special Issue
QbD Supported Optimization of the Alginate-Chitosan Nanoparticles of Simvastatin in Enhancing the Anti-Proliferative Activity against Tongue Carcinoma
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Application of Alginate-Based Hydrogels in Hemostasis

Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
*
Author to whom correspondence should be addressed.
Gels 2022, 8(2), 109; https://doi.org/10.3390/gels8020109
Submission received: 24 December 2021 / Revised: 31 January 2022 / Accepted: 3 February 2022 / Published: 10 February 2022

Abstract

:
Hemorrhage, as a common trauma injury and clinical postoperative complication, may cause serious damage to the body, especially for patients with huge blood loss and coagulation dysfunction. Timely and effective hemostasis and avoidance of bleeding are of great significance for reducing body damage and improving the survival rate and quality of life of patients. Alginate is considered to be an excellent hemostatic polymer-based biomaterial due to its excellent biocompatibility, biodegradability, non-toxicity, non-immunogenicity, easy gelation and easy availability. In recent years, alginate hydrogels have been more and more widely used in the medical field, and a series of hemostatic related products have been developed such as medical dressings, hemostatic needles, transcatheter interventional embolization preparations, microneedles, injectable hydrogels, and hemostatic powders. The development and application prospects are extremely broad. This manuscript reviews the structure, properties and history of alginate, as well as the research progress of alginate hydrogels in clinical applications related to hemostasis. This review also discusses the current limitations and possible future development prospects of alginate hydrogels in hemostatic applications.

1. Introduction

Various physical, chemical and human factors may lead to tissue trauma and cause bleeding. Deaths caused by trauma account for about 10% of all deaths worldwide, and blood loss is the most common preventable cause of death after trauma [1]. Hemorrhage and hemorrhagic shock cause 30–40% of traumatic deaths. As such, controlling bleeding in the early stage is a very suitable method to reduce mortality and incidence rate [2,3,4]. Furthermore, perioperative and inspection-related procedures can bring a risk of hemorrhage [4,5,6]. In order to reduce the damage caused by hemorrhage or avoid the occurrence of bleeding, to reduce the use of blood products and improve the survival rate and the quality of life of patients, techniques such as compression or pressing, thermoelectric cauterization, surgical ligation or suture, tourniquet, intravenous administration, and application of topical hemostatic agents have been used to control hemorrhage. The earliest history of treating trauma is the use of hot iron rods by European surgeons to stop bleeding in the 16th century. The history of applying hemostatic materials can be traced back to 1866 [7]. Appropriate hemostatic materials can significantly shorten the bleeding time and reduce the amount of blood products, which is of great significance for trauma or postoperative recovery [8]. The annual cost of complex wound care in North America is $10 billion, and globally, this cost may even exceed $22 billion by 2020, indicating that uncontrollable hemorrhage and wound infections cause a grave economic burden on society [9]. Therefore, the development of rapid, safe, effective and economical hemostatic materials is of great clinical and societal importance.
At present, commercially available hemostatic materials are oxidized cellulose, collagen (Col), gelatin (CE), polyethylene glycol (PEG) polymers, fibrin, thrombin, fibrinogen, cyanoacrylate (CA), porous zeolites, clay minerals, chitosan (CS) and alginate (AG), etc. They can all have a sterling hemostatic effect, however they also have some shortcomings. The carboxyl content of oxidized cellulose ranges from 16% to 24%, and the pH value is about 3.1. Low pH will make it cytotoxic and inactivate many bioactive ingredients, making it limited in its application to sensitive tissues and the combined use of bioactive drugs [10]. Collagen only relies on activating platelets for hemostasis, which is less effective in patients with severe thrombocytopenia and has poor tissue adhesion [11]. Fibrin, thrombin, and fibrinogen, as biologically derivatives, have a short shelf life and risk of disease transmission [12]. Porous zeolite will release large amounts of heat when it absorbs water from the blood, causing thermal damage and necrosis of the surrounding tissues [13,14,15]. Montmorillonite particles have been reported to enter the systemic circulation and cause endothelial damage and distal thrombosis in vital organs, and kaolin hemostatic agents may not be effective for patients with coagulopathy disorders [15,16]. Therefore, researchers have always been intensely interested in developing novel efficient and safe hemostatic materials.
The world has a vast ocean area and abundant ocean resources. With the development and exploration of the ocean, research into and the utilization of ocean resources have received more and more attention in recent years [17,18]. Marine polysaccharides have been widely used in biomedical fields due to their good biocompatibility, biodegradability, non-toxicity, and low prices, such as chitosan, alginate, hyaluronic acid and their derivatives [19,20,21]. Among them, alginate has become a favorite due to its unique advantages in hemostasis. Alginate has safety, biocompatibility, non-immunogenicity, high water absorption and the property of easily forming hydrogels [22,23]. This manuscript will briefly introduce alginate hydrogels, and comprehensively review the research and application progress of alginate hydrogels in medical hemostasis. It also considers the existing challenges, and hopes to contribute to the research on new hemostatic materials of alginate.

2. Alginate Hydrogels

2.1. Structure, Properties and History

Alginate is a natural anionic polysaccharide, which is a linear chain of β-D-mannuronic acid (M units) and α-L-guluronic acid (G units) linked via 1,4-glycosidic bond, mainly from brown algae and bacteria (Figure 1) [24]. Since the British chemist Standford first extracted alginate from brown algae in 1881, people have conducted extensive research on its physical and chemical properties [25,26]. It has been proven to have excellent biocompatibility, biodegradability and safety [27,28,29]. Alginate has been approved by the FDA as a material generally recognized as safe (GRAS) without special restrictions. Since the 1980s, the applications of alginate have rapidly expanded in food, chemical, printing, agriculture and medicine [24,30,31,32].
Alginic acid is insoluble in water, however the sodium alginate forms after binding Na+ can be completely dissolved in water. Hydrophilic sodium alginate can quickly form a hydrogel under extremely mild conditions [33]. In the presence of multivalent cations, the multivalent cations (Ca2+ is the most frequent ion) and the monovalent cations (Na+ is the most common ion) on the G blocks of alginate undergo an ion exchange reaction, and the G units accumulate to form egg-box conformational hydrogels (Figure 2) [34]. The properties of the hydrogels are related to the M/G composition, the molecular weight of the alginate, source of alginate, the cross-linked ion species and the ionic strength [25,35,36,37]. The rigidity of the alginate polymer chain shows the change of MG < MM < GG, and the increase in molecular weight and ionic strength will lead to the increase in solution viscosity value, which in turn affects the gel properties [25]. G blocks can cross-link with ions to form hydrogels, and high G content can improve the gel strength. Alginic acid can effectively combine various cations to form hydrogels, and the order of binding force is: Mg2+ < Mn2+ < Ca2+ < Sr2+ < Ba2+ < Cu2+ < Pa2+ [38,39]. Bacterial-derived alginic acid differs from algal-derived alginic acid in that there are different degrees of acetylated groups linked to D-mannose residues, resulting in better rheology and water absorption, but poor mechanical performance [40]. Due to the existence of bacterial endogenous alginate lyase, the molecular weight of bacterial-derived alginate varies greatly. In addition to production costs and other reasons, bacterial-derived alginate products are not very widespread. Due to its gelling ability, biocompatibility, non-immunogenicity, non-toxicity and safety, alginate has been widely used for hemostasis of various wounds.

2.2. Preparation of Alginate Hydrogels

Chemical and physical cross-linking are typical approaches used to form alginate hydrogels (Table 1). The cross-linking methods contain ion interaction, electrostatic interaction, microfluidic technique, divalent chelation, molecular entanglement, self-assemble, guest and host reaction, covalent cross-linking, hydrogen bonds and Schiff cross-linking [41,42]. The gels formed by ionic cross-linking are reversible. The reversibility is why the gels can be degraded in a physiological environment. The gelation rate and the gelation temperature can control gel uniformity and strength when ionic cross-linking [43]. Ionic cross-linking can be carried out by means of diffusion or by controlled triggering (typically the pH or solubility of the ion source) [44,45]. The covalent cross-linking of alginate hydrogels forms a three-dimensional network through copolymerization or polycondensation reaction induced by the cross-linking agent, which is irreversible. The physical properties of hydrogels can be improved by modification. If covalent cross-linking reagents have toxicity, the unreacted chemicals need to be removed thoroughly from gels. Cross-linking density and the reagent type are the main reasons for controlling the mechanical properties of the gels [46]. Chemical modification of alginate hydrogels is also a common means, typically with acetylation, phosphorylation and sulfation of alginate hydroxyl groups, oxidized of alginate and reductive amination of oxidized alginate, esterification and amidation of alginate carboxyl groups, ligation of bioactive ligands with alginate carboxyl groups, and modification of alginate via click chemistry reactions [44,47,48,49,50,51] (Figure 3). Oxidized alginate (OA) or partially oxidized alginate tissue adhesion performance is greatly promoted [52]. There is a continuous progress in the preparation and research of alginate stimuli-responsive hydrogels, such as heat-responsive hydrogels, pH-sensitive hydrogels and light-triggered hydrogels [53,54,55]. A single-component material is usually insufficient to provide enough mechanical properties, biodegradability, adhesion and hemostatic properties. Combined with other materials, alginate composite gels have better properties [56,57]. Then, the alginate gels can be applied to a wider field.

2.3. Hemostatic Mechanisms and Advantages of Alginate Hydrogels

Hydrogels are three-dimensional networks formed by cross-linking hydrophilic polymers, and the pores of the network can retain massive water or aqueous solution [69,70]. Hydrogels have become the primary choice of various hemostatic materials as they can simulate the natural cell environment, adapt to soft tissues/hard tissues, and have controllable biological, physical, and chemical properties [71,72]. Ideal hemostatic hydrogels should have fast gelation, good biocompatibility, excellent mechanical properties and sufficient adhesion [73,74]. Alginate hydrogels have gained significant attention in hemostasis, wound healing, and drug delivery as they can quickly form hydrogels under mild conditions and have a high water absorption swelling property, high oxygen permeability, mucosal adhesion property and good biocompatibility [75].
The alginate hemostatic materials form hydrogels after absorbing blood or body fluids, adhere to the wound surface, seal capillaries and small blood vessels, and physically compress the bleeding wound to achieve excellent hemostatic effects (Figure 4). Calcium alginate is the most common alginate hemostatic material. Calcium alginate hydrogels can promote the entry of calcium ions into the wound through the ion exchange reaction with sodium ions in the blood. Afterward, they stimulate the production of clotting factors VII, IX, and X, and platelets, activate the coagulation cascade reaction and accelerate the process of hemostasis [76]. Calcium alginate contains phytohemagglutinin, which can aggregate red blood cells and alter erythrocytes morphology, exposing phosphatidylserine on the surface of erythrocytes and accelerating local prothrombin conversion to thrombin [77]. In addition, alginate hydrogels can also be loaded with hemostatic drugs or bioactive ingredients to accelerate hemostasis and healing [78,79]. Alginate, in the form of hydrogels, appears in a series of hemostasis-related products such as medical dressings, hemostatic needles, transcatheter interventional embolization preparations, microneedles, injection agents and hemostatic powders.

3. Hemostasis of Superficial Wounds

Alginate materials are highly hygroscopic, moisturizing, and can effectively control hemorrhage and promote wound healing [81,82]. This characteristic is achieved through the formation of hydrogels. In 1962, Winter verified that a moist environment is more appropriate for wound healing than a dry environment [83]. In addition, the alginate fibers confined to the inside of the wound can be removed by biodegradation, without secondary damage to the tissue [84]. Alginate dressings are suitable for wet wounds, and they can play extraordinary roles in hemostasis and healing of superficial wounds.

3.1. Fibrous Dressings

When fibrous dressings in the dry form make contact with fluid, they can absorb the fluid and form gels, and the hydrogels can maintain a physiologically moist microenvironment and reduce bacterial infection at the wound site (Figure 5). The water absorption rate of pure alginate fiber is 2.2 times its own mass, which is suitable as a hemostatic dressing. Mohandas et al. manufactured alginate hydrogel/nano zinc oxide composite bandages, which had a porosity of 60–70% [85]. The bandages, which are an appropriate hemostatic dressing, can promote blood coagulation and epithelial regeneration. Umar et al. prepared bi-component alginate-hyaluronic acid (AHA) fibers [86]. Compared against commercially available alginate wound dressings (Dimora, marketed by Winner Medical Co., Ltd.), the dressing made of AHA fibers had better liquid absorption capacity and cell adhesion, indicating an overall better performance of the fibers produced by dope mixing. Zhang et al. used a blending method to add nanosilica/hydroxyapatite to alginate dressings, resulting in composites with high porosity [87]. Calcium alginate is common among commercially available dressings, and Ag+is usually incorporated to enhance the antibacterial properties of the dressings [88,89,90]. The addition of drug-loaded nanocapsules to alginate dressings using the wet spinning method can improve their mechanical properties and efficiently deliver drugs, favoring wound repair [91].

3.2. Films and Membranes

Alginate-based membranes and films are convenient to use and have good hemostatic and wound healing capacities, with water uptake of up to 985% in calcium alginate lyophilized membranes. Forming composite materials with other materials can promote their poor chemical stability and low mechanical strength [56]. Li et al. fabricated the blended alginate sodium/carboxymethyl chitosan membranes cross-linking dual-ion (Sr2+and Zn2+) (SA/CMCH IPN membranes) through a freeze-drying process [92]. The membrane exhibited excellent water uptake capacity and enhanced ability of cell adhesion, growth factor synthesis and angiogenesis. It is valuable in hemostasis and wound healing. Zhong et al. developed carboxymethyl chitosan/alginate/tranexamic acid composite films, with calcium chloride as the cross-linking agent and glycerin as a plasticizer. The composite membrane had better mechanical and barrier properties, and can slowly release the encapsulated tranexamic acid to accelerate blood coagulation. So, it has shown quite outstanding prospects in the development of hemostatic materials. Hong et al. PVA/HLC/SA hydrogels were prepared by repeated freezing and thawing methods, which were soft and elastic sheets [93]. The hydrogel dressings have excellent effects in swelling, hemostasis, antibacterial and so on. Then they are suitable for hemostasis and healing of traumatic wounds. Abou-Okeil et al. investigated the physical properties and antibacterial properties of hyaluronic acid (HA)/sodium alginate (SA) thin films cross-linked with different metal cations (Ca2+, Zn2+, Cu2+), as well as sulfadiazine and silver nanoparticles effects of incorporation into HA/SA/Ca2+ films as bioactive agents [94]. These films have good mechanical properties, water absorption and antibacterial properties, and are suitable as topical bioactive wound dressings. Koga et al. found that aloe/alginate films had good transparency and hemostatic efficiency, and were able to recruit leukocytes and promote wound healing [95]. Shafei used exosomes-loaded alginate hydrogel to study their application at skin wound sites and found that they greatly promoted wound closure, re-epithelialization, and angiogenesis [33]. Du et al. developed a hydrogel material with rapid self-healing and film formation after spraying, which can rapidly gel to form a spray film within 2–21 s [96]. It is a biomaterial suitable for treating large-scale and irregular wounds. Furthermore, sodium alginate can also be used as a hydrophilic coating to enhance the hemostatic ability of composite materials [97].

3.3. Hemostatic Sponges

The alginate-based sponges have a porous structure that can quickly absorb a large amount of water, concentrate plasma, stimulate the accumulation of endogenous coagulation factors in the injured area, and form hydrogels as physical barriers to stanch bleeding. They are indicated for large-area hemorrhage wounds and arterial injuries [98]. However, they are improper for uncontrollable and incompressible hemorrhage. Ma et al. prepared nanocomposite sponges of sodium alginate/graphene oxide (GO)/polyvinyl alcohol (SPG) by a freeze-thawing approach and freeze-dried molding [99]. Besides, GO promoted cell proliferation for wound healing and the sponges can load norfloxacin (NFX) to increase its antibacterial capacity. The sponges are suitable for hemostatic materials and wound dressing as a result of appropriate porosity, excellent water absorption and air permeability. Cheng et al. developed oxidized cellulose nanocrystal (TOCN)/alginate (SA) composites, of which the TOCN-30/SA composite sponges had the most efficient hemostatic efficiency [100]. Compared with nitrogen-filled sponges, the porosity, chemical stability and water absorption capacity of this composite sponges are improved, so they are more efficient hemostatic materials. Dowling et al. made hydrophobically-modified (hm) to alginic acid to enhance the adhesion capacity of the formed hydrogels [101]. Compared with the Kerlix™ gauze group, the obtained solid lyophilized sponges have obvious advantages in shortening the clotting time, controlling the amount of bleeding and increasing the clotting effect. This may serve as a safe and effective topical hemostatic agent.

4. Hemostasis of Vessel and Viscera

4.1. Hemostatic Needles

Hemorrhage after puncture of biological tissue with syringe needles is largely inevitable, and bleeding after puncture may lead to serious consequences [5]. The hemorrhage can be well controlled by hydrogel-coated hemostatic needles, which seal punctured tissue by a solid-to-gel phase transition in situ [102].
Ren et al. developed hemostatic needles coatings with alginate-CaCl2-based hydrogels, which can effectively prevent hemorrhage following tissue puncture (Figure 6 and Figure 7) [103]. The dry-formed hydrogels coatings on the needles can be converted into hydrogels upon hydration, and the adhesion of the hydrogels to the wound would be increased so that the hydrogels were separated from the needles when the needles were withdrawn and sealed the wound in situ. The coatings prepared by Alg-10%Ca precursor solutions had sterling uniformity and prominent mechanical properties. The evaluation of the adhesive strength of the coatings through the stainless-steel plates and porcine skin verified that the solid coatings will not fall off before puncture, whereas the hydrogels would adhere to the tissue after swelling. The results of hemostasis evaluation indicated that the needles with Alg-10%Ca coating exhibited universal synchronous hemostasis ability in venous blood vessels and internal organs. Alginate hydrogels coated needles can prevent bleeding after tissue puncture easily, rapidly and effectively, and have a promising application in injection and sampling. Inspired by this, Wei et al. secured a hydrogel made of sodium alginate, hyaluronic acid, and calcium carbonate [104]. The dried hydrogel coating can quickly reabsorb the aqueous solution to form a physical embolus to seal the puncture tract, resulting in effectively preventing blood loss. CD34 antibody within the hydrogel attracted progenitor cells to accelerate puncture tract healing. The hydrogel coating of the needle can act as a carrier for drugs to assist hemostasis and puncture wound healing by delivering drugs. Xu et al. also made a hydrogel composed of sodium alginate, hyaluronic acid, and calcium carbonate [105]. The hydrogel-coated needle successfully prevented the puncture and bleeding of AVF and AVG in rats. The hydrogel may be used to improve hemorrhage after AVF or AVG cannulation. Besides, Yin et al. synthesized gelatin–tannic acid composite hydrogels with high viscosity to achieve hemostasis in arterial puncture [106]. The excellent viscosity, mechanical strength and burst pressure of the hydrogels facilitated in situ hemostasis for arterial puncture. The hydrogels could produce hemostatic needles for different vessels.

4.2. Embolic Materials

Nowadays, minimally invasive transcatheter arterial embolization (TAE) is the best non-laparotomy option for rupture and bleeding of solid internal organs [107]. It is widely used in the treatment of cancer, aneurysm, parenchymal organ hemorrhage, gastrointestinal hemorrhage and postpartum hemorrhage [108,109,110]. The first documented arterial embolization operation was performed by Dawbain et al. in 1904 [111]. Standing embolic agents can cause chronic inflammation and even tissue damage. Gelatin particles are suitable for embolization hemostasis due to their non-antigenicity, good biocompatibility and degradability; however they cannot control the embolization precision well. The exploitation of novel and appropriate embolic agents is very important for the development of TAE [112,113,114]. In recent years, calcium alginate hydrogels have become a research hotspot of TAE embolization materials [115]. Many investigations of TAE have demonstrated the feasibility and effectiveness of TAE for hemostasis in visceral trauma or rupture and vascular embolization [116,117,118,119]. The alginate-based embolic agents can also cut off the blood supply of the tumor tissue and release the drug gradually at the embolization site, which are developed as dual-effect drugs for tumor embolization and chemotherapy [114,120]. Furthermore, they can be used in preoperative preparation for surgical procedures to prevent intraoperative bleeding. Becker et al. used the two-way injection method (PHG alginate, 2.5 wt%, via venous injection and CaCl2·2H2O, 0.68 M, via arterial injection) to test the biocompatibility and embolic properties of the calcium alginate hydrogels in rat kidney capsule and rabbit kidney, in determining their suitability as embolic materials [121]. Calcium alginate hydrogel was rapidly gelled in situ, acted as a stable polymer stopper to prevent all flow out of the kidney during the study, and had good biocompatibility. However, this two-way injection requires rich clinical experience and meticulous operation, which limits its use.
Sodium alginate microsphere vascular embolization agents (KMG) are widely used in interventional embolization therapy as a result of the following advantages: (1) They have good mechanical stability and biocompatibility, and do not cause chemical or immune reactions after embolization; (2) The final degradation products are polysaccharides that do not participate in the metabolic circulation of the human body; (3) They are quickly swell and are incarcerated after absorbing water, which effectively reduces accidental embolization; (4) They can embolize terminal arterioles. Rong et al. secured thrombin-loaded alginate-calcium microspheres (TACMs) by electrostatic droplet technology (Figure 8) [122,123]. TACMs mixed thrombus showed a significant increase in thrombin strength compared to the human own thrombus. The thrombin loaded in TACMs further shortens the clotting time. In the rabbit renal embolism model, bleeding completely stopped within 1.5 ± 1 min without embolic material reflux, and the survival rate of experimental animals was 100% in one week. It demonstrated that TACMs mixed thrombus had a good efficacy for transcatheter embolization of solid internal organ rupture and hemorrhage, and had clinical transformation potential. Research on alginate microspheres loaded with other drugs may develop more ideal embolic hemostatic products.

5. Hemostasis of Deep and Irregular Wounds

5.1. Injectable Hydrogels

The injectable hydrogels offer excellent features and enable the complete filling of deep and irregularly shaped wounds with hemorrhages, thereby forming effective mechanical barriers and reducing pain and scars (Figure 9). Injectable hydrogels can also conveniently and efficiently target delivery of encapsulated drugs to designated sites to assist in hemostasis or other therapeutic effects.
Zhai et al. fabricated a supramolecular hydrogel, the co-assembly of a cell adhesive peptide conjugate (Pept-1) and alginate (ALG), to control bleeding and promote wound healing [124]. Compared with Pept-1 hydrogel, the mechanical properties, hemostatic properties and wound healing capabilities of Pept-1/ALG hydrogel were greatly improved. In the hemostasis experiment in vitro, Pept-1/ALG hydrogel decreased the clotting time to 41 s, which was almost 28-fold faster than the control. In vivo hemostasis experiment, the blood loss in the Pept-1/ALG hydrogel treatment group was approximately 18% of that in the untreated control group. The alginate hydrogels are very promising for co-assembly with other biologically active ingredients to construct nanocomposite structures for hemostasis. Zhang et al. developed injectable in situ self-cross-linking hydrogels, made of sodium alginate, hemoglobin and carbon quantum dots (SA@Hb@CQDs) [125]. The hydrogels are versatile for rapid hemostasis, real-time monitoring, and chemokinetic therapy (CDT). In addition, the hydrogels are also antibacterial, promote wound healing and prevent tumor recurrence, which can be used for postoperative adjuvant therapy of cancer. Song et al. formed tissue-adhesive hemostatic hydrogels [126]. Alginate was selected as a primary polymer, which was oxidized for the Schiff base forming alginate and encoded with dopa. Dopa-OA hydrogels had high stiffness and elasticity, which can be used as a tissue glue for hemostasis. Oxidized sodium alginate improved the adhesion of the hydrogels to a certain extent [127]. Dopamine, as a mussel protein derivative material, can greatly improve the tissue adhesion ability of alginate hydrogels [61,128,129] (Figure 10). Kong et al. synthesized an injectable self-healing hydrogel containing CuS nanoparticles (CuS-NPs) based on N-carboxyethyl chitosan and oxidized sodium alginate [130]. This hemostatic material had good results in hemostasis, antibacterial and healing promotion, and due to its excellent self-healing and injectability, it can adapt well to the shape of the wound.

5.2. Microspheres

Microspheres are commonly prepared by spray drying, extrusion, and emulsification/gelation method, and, due to the large surface area and small volume, microspheres can fully contact the wound and enter narrow and small regions. Microspheres can produce micro/nano effects to promote blood absorption and cell adhesion, resulting in rapid hemostasis (within a few seconds). However, when encountering a large blood flow, they are easily washed away, so it is necessary to modify the raw materials and choose materials with special functions or composite materials to improve the efficiency of hemostasis.
Shi et al. developed composite microspheres made of carboxymethyl chitosan, sodium alginate, and collagen (CSCM), which can facilitate hemostasis [131]. Compared with the commercially available hemostatic agent (CMPHP), CSCM microspheres exhibited deeper pores and higher surface roughness, resulting in more platelets aggregation and adhesion, and have better hemostatic properties. CSCM may be useful in controlling hemorrhage in military and civilian emergencies. Huang et al. obtained silk fibroin (SF)/sodium alginate (SA) microspheres by emulsifying cross-linking [132]. The rough surface of SF/SA microspheres increased the cell adhesion ability. When the volume ratio of SA: SF was 2:1, the sample microspheres had the roughest surface and gathered the largest number of RBCs, leading to the fastest blood clotting rate. SF is natural fibrin, which can effectively improve the tissue adhesion of SA hydrogels. At the same time, SA can improve spheroidization and promote coagulation. SF/SA2 microspheres have the potential to be developed as a new type of hemostatic powder. Jia et al. and Zhang et al., respectively, prepared berberine-coated alginate-based composite microspheres [133,134]. The coated berberine enhanced the antibacterial capacity, water absorption capacity and biodegradability of the materials. The experimental groups with higher berberine content, such as SCC-10B (7%) and BACG-6B (6%), showed significantly enhanced hemostatic properties, indicating that these composite polysaccharides microspheres have potential value for hemostatic applications. Adhesive self-healing hydrogels can also be used for incompressible hemostasis, such as bone bleeding [135]. The Alginate-Based Composites obtained by Huang et al. combined the characteristics of sodium alginate (SA) and carboxymethyl chitosan (CMC) resulting in a better hemostatic effect than single-component SA or CMC, and good bioadhesive and degradable properties [136]. Wu et al. synthesized microspheres with a porous chitosan core and a compact calcium alginate shell layer [76]. The electrostatic adsorption of the chitosan core and the Ca2+ of calcium alginate worked together to achieve better hemostasis. They are suitable for severe bleeding in civil and war situations.

5.3. Hydrogel Beads

Simple instillation is a common method for producing alginate hydrogel beads, which can easily prepare gel particles encapsulated with various components and then be developed as hemostatic powders [137,138]. Liu et al. secured a hydrogel bead made of tissue factor (TF), collagen and alginate (TCA), which could play a role of good composite hemostatic [79]. Alginate, as the matrix of TAC beads, made contributions to entrapping TF-liposomes and collagen, absorbing water to form a hydrogel and controlling the release of TF. In vitro coagulation experiments, TCA beads, collagen/alginate beads, TF-liposomes/alginate beads, alginate beads and the control of recalcified blood alone required 4.5, 8.6, 6.2, 12.3 and 14.4 min to achieve coagulation, indicating TAC beads are a kind of potential hemostatic agent. Fathi et al. synthesized zeolite-loaded alginate-chitosan beads by a two-phase synthesis method, which targeted multiple mechanisms to improve hemostasis [139]. The electrostatic properties of chitosan enhanced the erythrocyte adhesion of beads. The porous structure of zeolite increased blood absorption and concentrated clotting factors. The hydrophilicity of alginate led to blood absorption and retention while playing a role as a physical barrier. The 4A4Z1C and 4A8Z1C beads induced coagulation within 15 s (14.4 ± 0.31 s and 14.76 ± 1.36 s). Due to their rapid hemostatic ability, the composite beads are expected to be used for traumatic bleeding control.

5.4. Microneedles

Microneedles (MNs) are a novel class of transdermal drug delivery systems (TDDS) with advantages such as pain relief, ease of application, low infection risk, controlled drug release, and efficient delivery [140]. The development of microneedles with hydrogel materials can be used for the sustained release of drugs and minimally invasive examination, which is beneficial as they reduce the occurrence of traumatic bleeding [141,142]. Microneedles or microneedle patches made of alginate composite materials can be used for sustained-release transdermal delivery of insulin, reducing the issues such as high bleeding probability, painful sensation, inconvenient life, and low compliance of diabetic patients due to multiple daily injections [142,143,144]. MNs can be used for cancer treatment, vaccine delivery, blood pressure control, etc. [145,146,147]. Percutaneous immunization of MNs has less risk of inducing inflammation and skin damage than intradermal injection, and is less likely to cause severe bleeding and complications. The implantable degradable microneedle patches can simultaneously have the excellent ability of rapid intraoperative hemostasis and long-term postoperative chemotherapy [148]. MNs also have great application space in minimally invasive examinations, such as examining or monitoring cytokines, glucose, cholesterol, etc. [149,150,151].

6. Conclusions and Future Perspectives

For people with acute massive blood loss or suffering from coagulation disorders, the body’s inherent hemostatic mechanism cannot meet the needs of timely hemostasis, and the existence of suitable hemostatic materials and technologies is very important. How to prevent the occurrence of bleeding events, stop bleeding in time and improve prognosis is of great clinical and social significance at present. The alginate-based hydrogels have biocompatibility, safety, water absorption, moisture retention and biodegradability, so they are well suited for application as hemostatic materials. Different types of alginate materials are suitable for hemostasis or prevention of bleeding in different situations (Table 2).
However, insufficient cell adhesion occurs due to a large number of negative charges on the surface of alginate materials and the lack of biochemical clumps that can adhere to cells. Alginate hydrogels mainly rely on divalent cations to be formed through physical cross-linking, and are sensitive to monovalent cations, citrate ions, chelating agents and phosphate ions, resulting in a construct that is not stable enough. The mechanical properties of sodium alginate after swelling are not ideal. Alginate hydrogel alone is not fast enough in hemostasis, and it is impossible to monitor wound healing. Through continuous exploration of chemical modification, composite components, changing the mode of application and loading drugs, alginate hydrogels can be improved in the mechanical properties, adhesion, stability, and hemostatic performance, thereby enabling alginate hydrogels to play a timelier and more effective role in hemostasis. In the future, low-cost, multi-function, composite combination, targeted delivery, in situ hemostasis with wound formation, loading of biologically active ingredients, and intelligent monitoring of wound healing may become the research direction of sodium alginate hydrogels.

Author Contributions

Y.X.: writing, review and editing, visualization. F.H., P.G.: review and editing. C.Z.: conceptualization, visualization, funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by funding from the National Natural Science Foundation of China (No. 81974096, No. 81770711, and No.81961138007) and ‘Program for HUST Academic Frontier Youth Team (2017QYTD20)’.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data is included in the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Naghavi, M.; Abajobir, A.A.; Abbafati, C.; Abbas, K.M.; Abd-Allah, F.; Abera, S.F.; Aboyans, V.; Adetokunboh, O.; Afshin, A.; Agrawal, A.; et al. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390, 1151–1210. [Google Scholar] [CrossRef] [Green Version]
  2. Kalkwarf, K.J.; Drake, S.A.; Yang, Y.; Thetford, C.; Myers, L.; Brock, M.; Wolf, D.A.; Persse, D.; Wade, C.E.; Holcomb, J.B. Bleeding to Death in a Big City: An Analysis of All Trauma Deaths from Hemorrhage in a Metropolitan Area during 1 Year. J. Trauma Acute Care Surg. 2020, 89, 716–722. [Google Scholar] [CrossRef] [PubMed]
  3. Gruen, R.L.; Brohi, K.; Schreiber, M.; Balogh, Z.J.; Pitt, V.; Narayan, M.; Maier, R.V. Haemorrhage Control in Severely Injured Patients. Lancet 2012, 380, 1099–1108. [Google Scholar] [CrossRef]
  4. Holcomb, J.B.; Moore, E.E.; Sperry, J.L.; Jansen, J.O.; Schreiber, M.A.; del Junco, D.J.; Spinella, P.C.; Sauaia, A.; Brohi, K.; Bulger, E.M.; et al. Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials. Ann. Surg. 2021, 273, 395. [Google Scholar] [CrossRef] [PubMed]
  5. Boyum, J.H.; Atwell, T.D.; Schmit, G.D.; Poterucha, J.J.; Schleck, C.D.; Harmsen, W.S.; Kamath, P.S. Incidence and Risk Factors for Adverse Events Related to Image-Guided Liver Biopsy. Mayo Clin. Proc. 2016, 91, 329–335. [Google Scholar] [CrossRef] [PubMed]
  6. Corapi, K.M.; Chen, J.L.T.; Balk, E.M.; Gordon, C.E. Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-Analysis. Am. J. Kidney Dis. 2012, 60, 62–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Palm, M.D.; Altman, J.S. Topical Hemostatic Agents: A Review. Dermatol. Surg. 2008, 34, 431–445. [Google Scholar] [CrossRef]
  8. Gabay, M.; Boucher, B.A. An Essential Primer for Understanding the Role of Topical Hemostats, Surgical Sealants, and Adhesives for Maintaining Hemostasis. Pharmacother. J. Hum. Pharmacol. Drug Ther. 2013, 33, 935–955. [Google Scholar] [CrossRef] [PubMed]
  9. Tricco, A.C.; Cogo, E.; Isaranuwatchai, W.; Khan, P.A.; Sanmugalingham, G.; Antony, J.; Hoch, J.S.; Straus, S.E. A Systematic Review of Cost-Effectiveness Analyses of Complex Wound Interventions Reveals Optimal Treatments for Specific Wound Types. BMC Med. 2015, 13, 90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Zhang, S.; Li, J.; Chen, S.; Zhang, X.; Ma, J.; He, J. Oxidized Cellulose-Based Hemostatic Materials. Carbohydr. Polym. 2020, 230, 115585. [Google Scholar] [CrossRef] [PubMed]
  11. Abbott, W.M.; Austen, W.G. The Effectiveness and Mechanism of Collagen-Induced Topical Hemostasis. Surgery 1975, 78, 723–729. [Google Scholar] [PubMed]
  12. Huang, L.; Liu, G.L.; Kaye, A.D.; Liu, H. Advances in Topical Hemostatic Agent Therapies: A Comprehensive Update. Adv. Ther. 2020, 37, 4132–4148. [Google Scholar] [CrossRef] [PubMed]
  13. Rhee, P.; Brown, C.; Martin, M.; Salim, A.; Plurad, D.; Green, D.; Chambers, L.; Demetriades, D.; Velmahos, G.; Alam, H. QuikClot Use in Trauma for Hemorrhage Control: Case Series of 103 Documented Uses. J. Trauma Acute Care Surg. 2008, 64, 1093–1099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Carraway, J.W.; Kent, D.; Young, K.; Cole, A.; Friedman, R.; Ward, K.R. Comparison of a New Mineral Based Hemostatic Agent to a Commercially Available Granular Zeolite Agent for Hemostasis in a Swine Model of Lethal Extremity Arterial Hemorrhage. Resuscitation 2008, 78, 230–235. [Google Scholar] [CrossRef] [PubMed]
  15. Pourshahrestani, S.; Zeimaran, E.; Djordjevic, I.; Kadri, N.A.; Towler, M.R. Inorganic Hemostats: The State-of-the-Art and Recent Advances. Mater. Sci. Eng. C 2016, 58, 1255–1268. [Google Scholar] [CrossRef] [PubMed]
  16. Kheirabadi, B.S.; Mace, J.E.; Terrazas, I.B.; Fedyk, C.G.; Estep, J.S.; Dubick, M.A.; Blackbourne, L.H. Safety Evaluation of New Hemostatic Agents, Smectite Granules, and Kaolin-Coated Gauze in a Vascular Injury Wound Model in Swine. J. Trauma Inj. Infect. Crit. Care 2010, 68, 269–278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug Development from Marine Natural Products. Nat. Rev. Drug Discov. 2009, 8, 69–85. [Google Scholar] [CrossRef] [PubMed]
  18. Snelgrove, P.V.R. An Ocean of Discovery: Biodiversity Beyond the Census of Marine Life. Planta Med. 2016, 82, 790–799. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Hu, Z.; Zhang, D.-Y.; Lu, S.-T.; Li, P.-W.; Li, S.-D. Chitosan-Based Composite Materials for Prospective Hemostatic Applications. Mar. Drugs 2018, 16, 273. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Rastogi, P.; Kandasubramanian, B. Review of Alginate-Based Hydrogel Bioprinting for Application in Tissue Engineering. Biofabrication 2019, 11, 042001. [Google Scholar] [CrossRef] [PubMed]
  21. Passi, A.; Vigetti, D. Hyaluronan as Tunable Drug Delivery System. Adv. Drug Deliv. Rev. 2019, 146, 83–96. [Google Scholar] [CrossRef]
  22. Chen, Y.; Wu, L.; Li, P.; Hao, X.; Yang, X.; Xi, G.; Liu, W.; Feng, Y.; He, H.; Shi, C. Polysaccharide Based Hemostatic Strategy for Ultrarapid Hemostasis. Macromol. Biosci. 2020, 20, 1900370. [Google Scholar] [CrossRef] [PubMed]
  23. Orive, G.; Ponce, S.; Hernández, R.M.; Gascón, A.R.; Igartua, M.; Pedraz, J.L. Biocompatibility of Microcapsules for Cell Immobilization Elaborated with Different Type of Alginates. Biomaterials 2002, 23, 3825–3831. [Google Scholar] [CrossRef]
  24. Zhong, H.; Gao, X.; Cheng, C.; Liu, C.; Wang, Q.; Han, X. The Structural Characteristics of Seaweed Polysaccharides and Their Application in Gel Drug Delivery Systems. Mar. Drugs 2020, 18, 658. [Google Scholar] [CrossRef] [PubMed]
  25. Lee, K.Y.; Mooney, D.J. Alginate: Properties and Biomedical Applications. Prog. Polym. Sci. 2012, 37, 106–126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Clementi, F. Alginate Production by Azotobacter Vinelandii. Crit. Rev. Biotechnol. 1997, 17, 327–361. [Google Scholar] [CrossRef]
  27. Hernández-González, A.C.; Téllez-Jurado, L.; Rodríguez-Lorenzo, L.M. Alginate Hydrogels for Bone Tissue Engineering, from Injectables to Bioprinting: A Review. Carbohydr. Polym. 2020, 229, 115514. [Google Scholar] [CrossRef]
  28. Uyen, N.T.T.; Hamid, Z.A.A.; Tram, N.X.T.; Ahmad, N. Fabrication of Alginate Microspheres for Drug Delivery: A Review. Int. J. Biol. Macromol. 2020, 153, 1035–1046. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, Y.; Fan, S.; Li, Y.; Niu, C.; Li, X.; Guo, Y.; Zhang, J.; Shi, J.; Wang, X. Silk Fibroin/Sodium Alginate Composite Porous Materials with Controllable Degradation. Int. J. Biol. Macromol. 2020, 150, 1314–1322. [Google Scholar] [CrossRef]
  30. Li, D.; Wei, Z.; Xue, C. Alginate-Based Delivery Systems for Food Bioactive Ingredients: An Overview of Recent Advances and Future Trends. Compr. Rev. Food Sci. Food Saf. 2021, 20, 5345–5369. [Google Scholar] [CrossRef]
  31. Cleetus, C.M.; Alvarez Primo, F.; Fregoso, G.; Lalitha Raveendran, N.; Noveron, J.C.; Spencer, C.T.; Ramana, C.V.; Joddar, B. Alginate Hydrogels with Embedded ZnO Nanoparticles for Wound Healing Therapy. Int. J. Nanomed. 2020, 15, 5097–5111. [Google Scholar] [CrossRef] [PubMed]
  32. Hazur, J.; Detsch, R.; Karakaya, E.; Kaschta, J.; Teßmar, J.; Schneidereit, D.; Friedrich, O.; Schubert, D.W.; Boccaccini, A.R. Improving Alginate Printability for Biofabrication: Establishment of a Universal and Homogeneous Pre-Crosslinking Technique. Biofabrication 2020, 12, 045004. [Google Scholar] [CrossRef] [PubMed]
  33. Shafei, S.; Khanmohammadi, M.; Heidari, R.; Ghanbari, H.; Taghdiri Nooshabadi, V.; Farzamfar, S.; Akbariqomi, M.; Sanikhani, N.S.; Absalan, M.; Tavoosidana, G. Exosome Loaded Alginate Hydrogel Promotes Tissue Regeneration in Full-Thickness Skin Wounds: An in Vivo Study. J. Biomed. Mater. Res. A 2020, 108, 545–556. [Google Scholar] [CrossRef] [PubMed]
  34. Augst, A.D.; Kong, H.J.; Mooney, D.J. Alginate Hydrogels as Biomaterials. Macromol. Biosci. 2006, 6, 623–633. [Google Scholar] [CrossRef]
  35. Rhein-Knudsen, N.; Ale, M.T.; Ajalloueian, F.; Meyer, A.S. Characterization of Alginates from Ghanaian Brown Seaweeds: Sargassum Spp. and Padina Spp. Food Hydrocoll. 2017, 71, 236–244. [Google Scholar] [CrossRef]
  36. Varaprasad, K.; Raghavendra, G.M.; Jayaramudu, T.; Seo, J. Nano Zinc Oxide–Sodium Alginate Antibacterial Cellulose Fibres. Carbohydr. Polym. 2016, 135, 349–355. [Google Scholar] [CrossRef]
  37. Núñez, C.; Peña, C.; Kloeckner, W.; Hernández-Eligio, A.; Bogachev, A.V.; Moreno, S.; Guzmán, J.; Büchs, J.; Espín, G. Alginate Synthesis in Azotobacter Vinelandii Is Increased by Reducing the Intracellular Production of Ubiquinone. Appl. Microbiol. Biotechnol. 2013, 97, 2503–2512. [Google Scholar] [CrossRef] [PubMed]
  38. Mørch, Ý.A.; Donati, I.; Strand, B.L.; Skjåk-Bræk, G. Effect of Ca2+, Ba2+, and Sr2+ on Alginate Microbeads. Biomacromolecules 2006, 7, 1471–1480. [Google Scholar] [CrossRef] [PubMed]
  39. Ching, S.H.; Bansal, N.; Bhandari, B. Alginate Gel Particles–A Review of Production Techniques and Physical Properties. Crit. Rev. Food Sci. Nutr. 2017, 57, 1133–1152. [Google Scholar] [CrossRef]
  40. Skjåk-Braek, G.; Grasdalen, H.; Larsen, B. Monomer Sequence and Acetylation Pattern in Some Bacterial Alginates. Carbohydr. Res. 1986, 154, 239–250. [Google Scholar] [CrossRef]
  41. Ahmed, E.M. Hydrogel: Preparation, Characterization, and Applications: A Review. J. Adv. Res. 2015, 6, 105–121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Zhang, M.; Zhao, X. Alginate Hydrogel Dressings for Advanced Wound Management. Int. J. Biol. Macromol. 2020, 162, 1414–1428. [Google Scholar] [CrossRef] [PubMed]
  43. Kuo, C.K.; Ma, P.X. Ionically Crosslinked Alginate Hydrogels as Scaffolds for Tissue Engineering: Part 1. Structure, Gelation Rate and Mechanical Properties. Biomaterials 2001, 22, 511–521. [Google Scholar] [CrossRef]
  44. Pawar, S.N.; Edgar, K.J. Alginate Derivatization: A Review of Chemistry, Properties and Applications. Biomaterials 2012, 33, 3279–3305. [Google Scholar] [CrossRef] [PubMed]
  45. Chen, D.; Amstad, E.; Zhao, C.-X.; Cai, L.; Fan, J.; Chen, Q.; Hai, M.; Koehler, S.; Zhang, H.; Liang, F.; et al. Biocompatible Amphiphilic Hydrogel–Solid Dimer Particles as Colloidal Surfactants. ACS Nano 2017, 11, 11978–11985. [Google Scholar] [CrossRef]
  46. Eiselt, P.; Lee, K.Y.; Mooney, D.J. Rigidity of Two-Component Hydrogels Prepared from Alginate and Poly(Ethylene Glycol)−Diamines. Macromolecules 1999, 32, 5561–5566. [Google Scholar] [CrossRef]
  47. Rosiak, P.; Latanska, I.; Paul, P.; Sujka, W.; Kolesinska, B. Modification of Alginates to Modulate Their Physic-Chemical Properties and Obtain Biomaterials with Different Functional Properties. Molecules 2021, 26, 7264. [Google Scholar] [CrossRef]
  48. Kim, H.-S.; Song, M.; Lee, E.-J.; Shin, U.S. Injectable Hydrogels Derived from Phosphorylated Alginic Acid Calcium Complexes. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 51, 139–147. [Google Scholar] [CrossRef]
  49. Chen, X.; Zhu, Q.; Liu, C.; Li, D.; Yan, H.; Lin, Q. Esterification of Alginate with Alkyl Bromides of Different Carbon Chain Lengths via the Bimolecular Nucleophilic Substitution Reaction: Synthesis, Characterization, and Controlled Release Performance. Polymers 2021, 13, 3351. [Google Scholar] [CrossRef]
  50. Distler, T.; McDonald, K.; Heid, S.; Karakaya, E.; Detsch, R.; Boccaccini, A.R. Ionically and Enzymatically Dual Cross-Linked Oxidized Alginate Gelatin Hydrogels with Tunable Stiffness and Degradation Behavior for Tissue Engineering. ACS Biomater. Sci. Eng. 2020, 6, 3899–3914. [Google Scholar] [CrossRef]
  51. Deng, Y.; Shavandi, A.; Okoro, O.V.; Nie, L. Alginate Modification via Click Chemistry for Biomedical Applications. Carbohydr. Polym. 2021, 270, 118360. [Google Scholar] [CrossRef] [PubMed]
  52. Reakasame, S.; Boccaccini, A.R. Oxidized Alginate-Based Hydrogels for Tissue Engineering Applications: A Review. Biomacromolecules 2018, 19, 3–21. [Google Scholar] [CrossRef] [PubMed]
  53. Dai, M.; Liu, Y.; Ju, B.; Tian, Y. Preparation of Thermoresponsive Alginate/Starch Ether Composite Hydrogel and Its Application to the Removal of Cu(II) from Aqueous Solution. Bioresour. Technol. 2019, 294, 122192. [Google Scholar] [CrossRef] [PubMed]
  54. Mahdavinia, G.R.; Rahmani, Z.; Karami, S.; Pourjavadi, A. Magnetic/PH-Sensitive κ-Carrageenan/Sodium Alginate Hydrogel Nanocomposite Beads: Preparation, Swelling Behavior, and Drug Delivery. J. Biomater. Sci. Polym. Ed. 2014, 25, 1891–1906. [Google Scholar] [CrossRef]
  55. Iatridi, Z.; Saravanou, S.-F.; Tsitsilianis, C. Injectable Self-Assembling Hydrogel from Alginate Grafted by P(N-Isopropylacrylamide-Co-N-Tert-Butylacrylamide) Random Copolymers. Carbohydr. Polym. 2019, 219, 344–352. [Google Scholar] [CrossRef] [PubMed]
  56. Varaprasad, K.; Jayaramudu, T.; Kanikireddy, V.; Toro, C.; Sadiku, E.R. Alginate-Based Composite Materials for Wound Dressing Application:A Mini Review. Carbohydr. Polym. 2020, 236, 116025. [Google Scholar] [CrossRef]
  57. Ionita, M.; Pandele, M.A.; Iovu, H. Sodium Alginate/Graphene Oxide Composite Films with Enhanced Thermal and Mechanical Properties. Carbohydr. Polym. 2013, 94, 339–344. [Google Scholar] [CrossRef] [PubMed]
  58. Wang, T.; Wang, J.; Wang, R.; Yuan, P.; Fan, Z.; Yang, S. Preparation and Properties of ZnO/Sodium Alginate Bi-Layered Hydrogel Films as Novel Wound Dressings. New J. Chem. 2019, 43, 8684–8693. [Google Scholar] [CrossRef]
  59. Zhao, L.; Yin, S.; Ma, Z. Ca2+-Triggered PH-Response Sodium Alginate Hydrogel Precipitation for Amplified Sandwich-Type Impedimetric Immunosensor of Tumor Marker. ACS Sens. 2019, 4, 450–455. [Google Scholar] [CrossRef] [PubMed]
  60. Hu, Y.; Zhang, Z.; Li, Y.; Ding, X.; Li, D.; Shen, C.; Xu, F.-J. Dual-Crosslinked Amorphous Polysaccharide Hydrogels Based on Chitosan/Alginate for Wound Healing Applications. Macromol. Rapid Commun. 2018, 39, 1800069. [Google Scholar] [CrossRef]
  61. Chen, T.; Chen, Y.; Rehman, H.U.; Chen, Z.; Yang, Z.; Wang, M.; Li, H.; Liu, H. Ultratough, Self-Healing, and Tissue-Adhesive Hydrogel for Wound Dressing. ACS Appl. Mater. Interfaces 2018, 10, 33523–33531. [Google Scholar] [CrossRef] [PubMed]
  62. Liang, M.; Chen, Z.; Wang, F.; Liu, L.; Wei, R.; Zhang, M. Preparation of Self-Regulating/Anti-Adhesive Hydrogels and Their Ability to Promote Healing in Burn Wounds. J. Biomed. Mater. Res. B Appl. Biomater. 2019, 107, 1471–1482. [Google Scholar] [CrossRef]
  63. Jin, S.G.; Kim, K.S.; Kim, D.W.; Kim, D.S.; Seo, Y.G.; Go, T.G.; Youn, Y.S.; Kim, J.O.; Yong, C.S.; Choi, H.-G. Development of a Novel Sodium Fusidate-Loaded Triple Polymer Hydrogel Wound Dressing: Mechanical Properties and Effects on Wound Repair. Int. J. Pharm. 2016, 497, 114–122. [Google Scholar] [CrossRef] [PubMed]
  64. Quah, S.P.; Nykypanchuk, D.; Bhatia, S.R. Temperature-Dependent Structure and Compressive Mechanical Behavior of Alginate/Polyethylene Oxide–Poly(Propylene Oxide)–Poly(Ethylene Oxide) Hydrogels. J. Biomed. Mater. Res. B Appl. Biomater. 2020, 108, 834–844. [Google Scholar] [CrossRef] [PubMed]
  65. Ooi, H.W.; Kocken, J.M.M.; Morgan, F.L.C.; Malheiro, A.; Zoetebier, B.; Karperien, M.; Wieringa, P.A.; Dijkstra, P.J.; Moroni, L.; Baker, M.B. Multivalency Enables Dynamic Supramolecular Host–Guest Hydrogel Formation. Biomacromolecules 2020, 21, 2208–2217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Khampieng, T.; Wongkittithavorn, S.; Chaiarwut, S.; Ekabutr, P.; Pavasant, P.; Supaphol, P. Silver Nanoparticles-Based Hydrogel: Characterization of Material Parameters for Pressure Ulcer Dressing Applications. J. Drug Deliv. Sci. Technol. 2018, 44, 91–100. [Google Scholar] [CrossRef]
  67. Golafshan, N.; Rezahasani, R.; Tarkesh Esfahani, M.; Kharaziha, M.; Khorasani, S.N. Nanohybrid Hydrogels of Laponite: PVA-Alginate as a Potential Wound Healing Material. Carbohydr. Polym. 2017, 176, 392–401. [Google Scholar] [CrossRef] [PubMed]
  68. Mousavi, A.; Mashayekhan, S.; Baheiraei, N.; Pourjavadi, A. Biohybrid Oxidized Alginate/Myocardial Extracellular Matrix Injectable Hydrogels with Improved Electromechanical Properties for Cardiac Tissue Engineering. Int. J. Biol. Macromol. 2021, 180, 692–708. [Google Scholar] [CrossRef] [PubMed]
  69. Mo, C.; Xiang, L.; Chen, Y. Advances in Injectable and Self-Healing Polysaccharide Hydrogel Based on the Schiff Base Reaction. Macromol. Rapid Commun. 2021, 42, 2100025. [Google Scholar] [CrossRef] [PubMed]
  70. Li, Y.; Yang, H.Y.; Lee, D.S. Advances in Biodegradable and Injectable Hydrogels for Biomedical Applications. J. Controlled Release 2021, 330, 151–160. [Google Scholar] [CrossRef] [PubMed]
  71. Aderibigbe, B.; Buyana, B. Alginate in Wound Dressings. Pharmaceutics 2018, 10, 42. [Google Scholar] [CrossRef] [Green Version]
  72. Zhang, Y.S.; Khademhosseini, A. Advances in Engineering Hydrogels. Science 2017, 356, eaaf3627. [Google Scholar] [CrossRef] [PubMed]
  73. Patenaude, M.; Smeets, N.M.B.; Hoare, T. Designing Injectable, Covalently Cross-Linked Hydrogels for Biomedical Applications. Macromol. Rapid Commun. 2014, 35, 598–617. [Google Scholar] [CrossRef] [PubMed]
  74. Li, J.; Celiz, A.D.; Yang, J.; Yang, Q.; Wamala, I.; Whyte, W.; Seo, B.R.; Vasilyev, N.V.; Vlassak, J.J.; Suo, Z.; et al. Tough Adhesives for Diverse Wet Surfaces. Science 2017, 357, 378–381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Zheng, B.-D.; Ye, J.; Yang, Y.-C.; Huang, Y.-Y.; Xiao, M.-T. Self-Healing Polysaccharide-Based Injectable Hydrogels with Antibacterial Activity for Wound Healing. Carbohydr. Polym. 2022, 275, 118770. [Google Scholar] [CrossRef] [PubMed]
  76. Wu, X.; Tang, Z.; Liao, X.; Wang, Z.; Liu, H. Fabrication of Chitosan@calcium Alginate Microspheres with Porous Core and Compact Shell, and Application as a Quick Traumatic Hemostat. Carbohydr. Polym. 2020, 247, 116669. [Google Scholar] [CrossRef]
  77. Wang, L.; Li, W.; Qin, S. Three Polymers from the Sea: Unique Structures, Directional Modifications, and Medical Applications. Polymers 2021, 13, 2482. [Google Scholar] [CrossRef] [PubMed]
  78. Ehterami, A.; Salehi, M.; Farzamfar, S.; Samadian, H.; Vaez, A.; Ghorbani, S.; Ai, J.; Sahrapeyma, H. Chitosan/Alginate Hydrogels Containing Alpha-Tocopherol for Wound Healing in Rat Model. J. Drug Deliv. Sci. Technol. 2019, 51, 204–213. [Google Scholar] [CrossRef]
  79. Liu, C.; Shi, Z.; Sun, H.; Zhao, L.; Wang, X.; Huang, F. Tissue Factor-loaded Collagen/Alginate Hydrogel Beads as a Hemostatic Agent. J. Biomed. Mater. Res. B Appl. Biomater. 2021, 109, 1116–1123. [Google Scholar] [CrossRef] [PubMed]
  80. Pourshahrestani, S.; Zeimaran, E.; Kadri, N.A.; Mutlu, N.; Boccaccini, A.R. Polymeric Hydrogel Systems as Emerging Biomaterial Platforms to Enable Hemostasis and Wound Healing. Adv. Healthc. Mater. 2020, 9, 2000905. [Google Scholar] [CrossRef] [PubMed]
  81. Kim, J.O.; Park, J.K.; Kim, J.H.; Jin, S.G.; Yong, C.S.; Li, D.X.; Choi, J.Y.; Woo, J.S.; Yoo, B.K.; Lyoo, W.S.; et al. Development of Polyvinyl Alcohol-Sodium Alginate Gel-Matrix-Based Wound Dressing System Containing Nitrofurazone. Int. J. Pharm. 2008, 359, 79–86. [Google Scholar] [CrossRef] [PubMed]
  82. Thomas, A.; Harding, K.G.; Moore, K. Alginates from Wound Dressings Activate Human Macrophages to Secrete Tumour Necrosis Factor-α. Biomaterials 2000, 21, 1797–1802. [Google Scholar] [CrossRef]
  83. Winter, G.D. Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the Skin of the Young Domestic Pig. Nature 1962, 193, 293–294. [Google Scholar] [CrossRef] [PubMed]
  84. Gilchrist, T.; Martin, A.M. Wound Treatment with Sorbsan—An Alginate Fibre Dressing. Biomaterials 1983, 4, 317–320. [Google Scholar] [CrossRef]
  85. Mohandas, A.; Pt, S.K.; Raja, B.; Lakshmanan, V.-K.; Jayakumar, R. Exploration of Alginate Hydrogel/Nano Zinc Oxide Composite Bandages for Infected Wounds. Int. J. Nanomedicine 2015, 10, 53–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Wet-Spun Bi-Component Alginate Based Hydrogel Fibers: Development and in-Vitro Evaluation as a Potential Moist Wound Care Dressing. Int. J. Biol. Macromol. 2021, 168, 601–610. [CrossRef] [PubMed]
  87. Zhang, X.; Huang, C.; Zhao, Y.; Jin, X. Preparation and Characterization of Nanoparticle Reinforced Alginate Fibers with High Porosity for Potential Wound Dressing Application. RSC Adv. 2017, 7, 39349–39358. [Google Scholar] [CrossRef] [Green Version]
  88. Castellano, J.J.; Shafii, S.M.; Ko, F.; Donate, G.; Wright, T.E.; Mannari, R.J.; Payne, W.G.; Smith, D.J.; Robson, M.C. Comparative Evaluation of Silver-Containing Antimicrobial Dressings and Drugs. Int. Wound J. 2007, 4, 114–122. [Google Scholar] [CrossRef] [PubMed]
  89. Qin, Y. Novel Antimicrobial Fibres. Text. Mag. 2004, 31, 14–17. [Google Scholar]
  90. Qin, Y. Silver-Containing Alginate Fibres and Dressings. Int. Wound J. 2005, 2, 172–176. [Google Scholar] [CrossRef] [PubMed]
  91. Liu, L.; Jiang, L.; Xu, G.K.; Ma, C.; Yang, X.G.; Yao, J.M. Potential of Alginate Fibers Incorporated with Drug-Loaded Nanocapsules as Drug Delivery Systems. J. Mater. Chem. B 2014, 2, 7596–7604. [Google Scholar] [CrossRef] [PubMed]
  92. Li, Z.; Chen, S.; Wu, B.; Liu, Z.; Cheng, L.; Bao, Y.; Ma, Y.; Chen, L.; Tong, X.; Dai, F. Multifunctional Dual Ionic-Covalent Membranes for Wound Healing. ACS Biomater. Sci. Eng. 2020, 6, 6949–6960. [Google Scholar] [CrossRef]
  93. Pan, H.; Fan, D.; Duan, Z.; Zhu, C.; Fu, R.; Li, X. Non-Stick Hemostasis Hydrogels as Dressings with Bacterial Barrier Activity for Cutaneous Wound Healing. Mater. Sci. Eng. C 2019, 105, 110118. [Google Scholar] [CrossRef]
  94. Abou-Okeil, A.; Fahmy, H.M.; El-Bisi, M.K.; Ahmed-Farid, O.A. Hyaluronic Acid/Na-Alginate Films as Topical Bioactive Wound Dressings. Eur. Polym. J. 2018, 109, 101–109. [Google Scholar] [CrossRef]
  95. Koga, A.Y.; Pereira, A.V.; Lipinski, L.C.; Oliveira, M.R.P. Evaluation of Wound Healing Effect of Alginate Films Containing Aloe Vera (Aloe Barbadensis Miller) Gel. J. Biomater. Appl. 2018, 32, 1212–1221. [Google Scholar] [CrossRef]
  96. Du, Y.; Li, L.; Peng, H.; Zheng, H.; Cao, S.; Lv, G.; Yang, A.; Li, H.; Liu, T. A Spray-Filming Self-Healing Hydrogel Fabricated from Modified Sodium Alginate and Gelatin as a Bacterial Barrier. Macromol. Biosci. 2020, 20, 1900303. [Google Scholar] [CrossRef] [PubMed]
  97. Lv, C.; Li, L.; Jiao, Z.; Yan, H.; Wang, Z.; Wu, Z.; Guo, M.; Wang, Y.; Zhang, P. Improved Hemostatic Effects by Fe3+ Modified Biomimetic PLLA Cotton-like Mat via Sodium Alginate Grafted with Dopamine. Bioact. Mater. 2021, 6, 2346–2359. [Google Scholar] [CrossRef]
  98. Severinov, D.A.; Lazarenko, S.V.; Sotnikov, K.A.; Pohozhay, V.V.; Ansimova, P.V.; Lipatov, V.A. In Vitro Evaluation of Performance Properties of Sponge Hemostatic Dressings (Review). Mod. Technol. Med. 2020, 12, 139–146. [Google Scholar] [CrossRef] [PubMed]
  99. Ma, R.; Wang, Y.; Qi, H.; Shi, C.; Wei, G.; Xiao, L.; Huang, Z.; Liu, S.; Yu, H.; Teng, C.; et al. Nanocomposite Sponges of Sodium Alginate/Graphene Oxide/Polyvinyl Alcohol as Potential Wound Dressing: In Vitro and in Vivo Evaluation. Compos. Part B Eng. 2019, 167, 396–405. [Google Scholar] [CrossRef]
  100. Cheng, F.; Liu, C.; Wei, X.; Yan, T.; Li, H.; He, J.; Huang, Y. Preparation and Characterization of 2,2,6,6-Tetramethylpiperidine-1-Oxyl (TEMPO)-Oxidized Cellulose Nanocrystal/Alginate Biodegradable Composite Dressing for Hemostasis Applications. ACS Sustain. Chem. Eng. 2017, 5, 3819–3828. [Google Scholar] [CrossRef]
  101. Dowling, M.B.; Chaturvedi, A.; MacIntire, I.C.; Javvaji, V.; Gustin, J.; Raghavan, S.R.; Scalea, T.M.; Narayan, M. Determination of Efficacy of a Novel Alginate Dressing in a Lethal Arterial Injury Model in Swine. Injury 2016, 47, 2105–2109. [Google Scholar] [CrossRef] [Green Version]
  102. Shin, M.; Park, S.-G.; Oh, B.-C.; Kim, K.; Jo, S.; Lee, M.S.; Oh, S.S.; Hong, S.-H.; Shin, E.-C.; Kim, K.-S.; et al. Complete Prevention of Blood Loss with Self-Sealing Haemostatic Needles. Nat. Mater. 2017, 16, 147–152. [Google Scholar] [CrossRef]
  103. Ren, J.; Yin, X.; Chen, Y.; Chen, Y.; Su, H.; Wang, K.; Zhang, L.; Zhu, J.; Zhang, C. Alginate Hydrogel-Coated Syringe Needles for Rapid Haemostasis of Vessel and Viscera Puncture. Biomaterials 2020, 249, 120019. [Google Scholar] [CrossRef]
  104. Wei, S.; Xu, Y.; Wang, Z.; Li, M.; Sun, P.; Xie, B.; Xing, Y.; Bai, H.; Kan, Q.; Li, J.; et al. Hydrogel-Coated Needles Prevent Puncture Site Bleeding. Acta Biomater. 2021, 128, 305–313. [Google Scholar] [CrossRef] [PubMed]
  105. Xu, Y.; Wang, Z.; Wei, S.; Sun, P.; Bai, H.; Li, J. Hydrogel-Coated Needles Prevent Puncture Site Bleeding in Arteriovenous Fistula and Arteriovenous Grafts in Rats. Biomed. Pharmacother. 2021, 143, 112113. [Google Scholar] [CrossRef]
  106. Yin, X.; Ren, J.; Lan, W.; Chen, Y.; Ouyang, M.; Su, H.; Zhang, L.; Zhu, J.; Zhang, C. Microfluidics-Assisted Optimization of Highly Adhesive Haemostatic Hydrogel Coating for Arterial Puncture. Bioact. Mater. 2021. [Google Scholar] [CrossRef]
  107. Haan, J.M.; Bochicchio, G.V.; Kramer, N.; Scalea, T.M. Nonoperative Management of Blunt Splenic Injury: A 5-Year Experience. J. Trauma Acute Care Surg. 2005, 58, 492–498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Choi, H.; Choi, B.; Yu, B.; Li, W.; Matsumoto, M.M.; Harris, K.R.; Lewandowski, R.J.; Larson, A.C.; Mouli, S.K.; Kim, D.-H. On-Demand Degradable Embolic Microspheres for Immediate Restoration of Blood Flow during Image-Guided Embolization Procedures. Biomaterials 2021, 265, 120408. [Google Scholar] [CrossRef]
  109. Chen, C.; Lee, S.M.; Kim, J.W.; Shin, J.H. Recent Update of Embolization of Postpartum Hemorrhage. Korean J. Radiol. 2018, 19, 585–596. [Google Scholar] [CrossRef]
  110. Jander, H.P.; Russinovich, N.A. Transcatheter Gelfoam Embolization in Abdominal, Retroperitoneal, and Pelvic Hemorrhage. Radiology 1980, 136, 337–344. [Google Scholar] [CrossRef] [PubMed]
  111. Dawbarn, R.H.M. The starvation operation for malignancy in the external carotid area.its failures and successes. J. Am. Med. Assoc. 1904, XLIII, 792–795. [Google Scholar] [CrossRef]
  112. Skattum, J.; Titze, T.L.; Dormagen, J.B.; Aaberge, I.S.; Bechensteen, A.G.; Gaarder, P.I.; Gaarder, C.; Heier, H.E.; Næss, P.A. Preserved Splenic Function after Angioembolisation of High Grade Injury. Injury 2012, 43, 62–66. [Google Scholar] [CrossRef] [PubMed]
  113. Abada, H.T.; Golzarian, J. Gelatine Sponge Particles: Handling Characteristics for Endovascular Use. Tech. Vasc. Interv. Radiol. 2007, 10, 257–260. [Google Scholar] [CrossRef]
  114. Alfidja, A.; Garcier, J.-M.; Chahid, T.; Ravel, A.; Boyer, L. Endovascular Therapeutic Techniques. EMC-Radiol. 2004, 1, 216–232. [Google Scholar] [CrossRef]
  115. Hu, J.; Albadawi, H.; Chong, B.W.; Deipolyi, A.R.; Sheth, R.A.; Khademhosseini, A.; Oklu, R. Advances in Biomaterials and Technologies for Vascular Embolization. Adv. Mater. 2019, 31, 1901071. [Google Scholar] [CrossRef]
  116. Du, N.; Ma, J.-Q.; Luo, J.-J.; Liu, Q.-X.; Zhang, Z.-H.; Yang, M.-J.; Yu, T.-Z.; Tao, Y.; Liu, R.; Zhang, W.; et al. The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy. Biomed Res. Int. 2019, 2019, e6265183. [Google Scholar] [CrossRef]
  117. Liao, C.-H.; Ouyang, C.-H.; Fu, C.-Y.; Wang, S.-Y.; Lin, K.-J.; Kuo, I.-M.; Hsu, C.-P.; Yang, S.-J.; Yuan, K.-C.; Hsu, Y.-P. The Current Status and Management of Blunt Adrenal Gland Trauma. Surgery 2015, 157, 338–343. [Google Scholar] [CrossRef]
  118. Yoshida, H.; Mamada, Y.; Taniai, N.; Uchida, E. Spontaneous Ruptured Hepatocellular Carcinoma. Hepatol. Res. 2016, 46, 13–21. [Google Scholar] [CrossRef]
  119. Yao, Z.; Tian, W.; Xu, X.; Zhao, R.; Huang, M.; Zhao, Y.; Chen, X. Transcatheter Arterial Embolization in the Treatment of Abdominal Bleeding in Patients Being Treated with Open Abdomen Due to Duodenal Fistula. World J. Surg. 2020, 44, 2562–2571. [Google Scholar] [CrossRef] [PubMed]
  120. Fan, L.; Duan, M.; Xie, Z.; Pan, K.; Wang, X.; Sun, X.; Wang, Q.; Rao, W.; Liu, J. Injectable and Radiopaque Liquid Metal/Calcium Alginate Hydrogels for Endovascular Embolization and Tumor Embolotherapy. Small 2020, 16, 1903421. [Google Scholar] [CrossRef] [PubMed]
  121. Becker, T.A.; Kipke, D.R.; Brandon, T. Calcium Alginate Gel: A Biocompatible and Mechanically Stable Polymer for Endovascular Embolization. J. Biomed. Mater. Res. 2001, 54, 76–86. [Google Scholar] [CrossRef]
  122. Rong, J.; Liang, M.; Xuan, F.; Sun, J.; Zhao, L.; Zheng, H.; Tian, X.; Liu, D.; Zhang, Q.; Peng, C.; et al. Thrombin-Loaded Alginate-Calcium Microspheres: A Novel Hemostatic Embolic Material for Transcatheter Arterial Embolization. Int. J. Biol. Macromol. 2017, 104, 1302–1312. [Google Scholar] [CrossRef]
  123. Rong, J.; Liang, M.; Xuan, F.; Sun, J.; Zhao, L.; Zhen, H.; Tian, X.; Liu, D.; Zhang, Q.; Peng, C.; et al. Alginate-Calcium Microsphere Loaded with Thrombin: A New Composite Biomaterial for Hemostatic Embolization. Int. J. Biol. Macromol. 2015, 75, 479–488. [Google Scholar] [CrossRef] [PubMed]
  124. Zhai, Z.; Xu, K.; Mei, L.; Wu, C.; Liu, J.; Liu, Z.; Wan, L.; Zhong, W. Co-Assembled Supramolecular Hydrogels of Cell Adhesive Peptide and Alginate for Rapid Hemostasis and Efficacious Wound Healing. Soft Matter 2019, 15, 8603–8610. [Google Scholar] [CrossRef]
  125. Zhang, Q.; Li, Z.; Zhang, M.; Wang, W.; Shen, J.; Ye, Z.; Zhou, N. Injectable In Situ Self-Cross-Linking Hydrogels Based on Hemoglobin, Carbon Quantum Dots, and Sodium Alginate for Real-Time Detection of Wound Bacterial Infection and Efficient Postoperative Prevention of Tumor Recurrence. Langmuir 2020, 36, 13263–13273. [Google Scholar] [CrossRef] [PubMed]
  126. Song, C.K.; Kim, M.-K.; Lee, J.; Davaa, E.; Baskaran, R.; Yang, S.-G. Dopa-Empowered Schiff Base Forming Alginate Hydrogel Glue for Rapid Hemostatic Control. Macromol. Res. 2019, 27, 119–125. [Google Scholar] [CrossRef]
  127. Balakrishnan, B.; Joshi, N.; Jayakrishnan, A.; Banerjee, R. Self-Crosslinked Oxidized Alginate/Gelatin Hydrogel as Injectable, Adhesive Biomimetic Scaffolds for Cartilage Regeneration. Acta Biomater. 2014, 10, 3650–3663. [Google Scholar] [CrossRef] [PubMed]
  128. Hou, J.; Li, C.; Guan, Y.; Zhang, Y.; Zhu, X.X. Enzymatically Crosslinked Alginate Hydrogels with Improved Adhesion Properties. Polym. Chem. 2015, 6, 2204–2213. [Google Scholar] [CrossRef]
  129. Zhang, H.; Bré, L.P.; Zhao, T.; Zheng, Y.; Newland, B.; Wang, W. Mussel-Inspired Hyperbranched Poly(Amino Ester) Polymer as Strong Wet Tissue Adhesive. Biomaterials 2014, 35, 711–719. [Google Scholar] [CrossRef]
  130. Kong, Y.; Hou, Z.; Zhou, L.; Zhang, P.; Ouyang, Y.; Wang, P.; Chen, Y.; Luo, X. Injectable Self-Healing Hydrogels Containing CuS Nanoparticles with Abilities of Hemostasis, Antibacterial Activity, and Promoting Wound Healing. ACS Biomater. Sci. Eng. 2021, 7, 335–349. [Google Scholar] [CrossRef] [PubMed]
  131. Shi, X.; Fang, Q.; Ding, M.; Wu, J.; Ye, F.; Lv, Z.; Jin, J. Microspheres of Carboxymethyl Chitosan, Sodium Alginate and Collagen for a Novel Hemostatic in Vitro Study. J. Biomater. Appl. 2016, 30, 1092–1102. [Google Scholar] [CrossRef] [PubMed]
  132. Huang, X.; Fu, Q.; Deng, Y.; Wang, F.; Xia, B.; Chen, Z.; Chen, G. Surface Roughness of Silk Fibroin/Alginate Microspheres for Rapid Hemostasis in Vitro and in Vivo. Carbohydr. Polym. 2021, 253, 117256. [Google Scholar] [CrossRef] [PubMed]
  133. Jin, J.; Xu, M.; Liu, Y.; Ji, Z.; Dai, K.; Zhang, L.; Wang, L.; Ye, F.; Chen, G.; Lv, Z. Alginate-Based Composite Microspheres Coated by Berberine Simultaneously Improve Hemostatic and Antibacterial Efficacy. Colloids Surf. B Biointerfaces 2020, 194, 111168. [Google Scholar] [CrossRef] [PubMed]
  134. Zhang, X.; Dai, K.; Liu, C.; Hu, H.; Luo, F.; Qi, Q.; Wang, L.; Ye, F.; Jin, J.; Tang, J.; et al. Berberine-Coated Biomimetic Composite Microspheres for Simultaneously Hemostatic and Antibacterial Performance. Polymers 2021, 13, 360. [Google Scholar] [CrossRef] [PubMed]
  135. Huang, W.; Cheng, S.; Wang, X.; Zhang, Y.; Chen, L.; Zhang, L. Noncompressible Hemostasis and Bone Regeneration Induced by an Absorbable Bioadhesive Self-Healing Hydrogel. Adv. Funct. Mater. 2021, 31, 2009189. [Google Scholar] [CrossRef]
  136. Huang, H.; Chen, H.; Wang, X.; Qiu, F.; Liu, H.; Lu, J.; Tong, L.; Yang, Y.; Wang, X.; Wu, H. Degradable and Bioadhesive Alginate-Based Composites: An Effective Hemostatic Agent. ACS Biomater. Sci. Eng. 2019, 5, 5498–5505. [Google Scholar] [CrossRef]
  137. Lee, B.-B.; Ravindra, P.; Chan, E.-S. Size and Shape of Calcium Alginate Beads Produced by Extrusion Dripping. Chem. Eng. Technol. 2013, 36, 1627–1642. [Google Scholar] [CrossRef]
  138. Chan, E.-S.; Lim, T.-K.; Voo, W.-P.; Pogaku, R.; Tey, B.T.; Zhang, Z. Effect of Formulation of Alginate Beads on Their Mechanical Behavior and Stiffness. Particuology 2011, 9, 228–234. [Google Scholar] [CrossRef]
  139. Fathi, P.; Sikorski, M.; Christodoulides, K.; Langan, K.; Choi, Y.S.; Titcomb, M.; Ghodasara, A.; Wonodi, O.; Thaker, H.; Vural, M.; et al. Zeolite-Loaded Alginate-Chitosan Hydrogel Beads as a Topical Hemostat. J. Biomed. Mater. Res. B Appl. Biomater. 2018, 106, 1662–1671. [Google Scholar] [CrossRef] [PubMed]
  140. Dabholkar, N.; Gorantla, S.; Waghule, T.; Rapalli, V.K.; Kothuru, A.; Goel, S.; Singhvi, G. Biodegradable Microneedles Fabricated with Carbohydrates and Proteins: Revolutionary Approach for Transdermal Drug Delivery. Int. J. Biol. Macromol. 2021, 170, 602–621. [Google Scholar] [CrossRef] [PubMed]
  141. Al Sulaiman, D.; Chang, J.Y.H.; Bennett, N.R.; Topouzi, H.; Higgins, C.A.; Irvine, D.J.; Ladame, S. Hydrogel-Coated Microneedle Arrays for Minimally Invasive Sampling and Sensing of Specific Circulating Nucleic Acids from Skin Interstitial Fluid. ACS Nano 2019, 13, 9620–9628. [Google Scholar] [CrossRef] [PubMed]
  142. Chen, W.; Tian, R.; Xu, C.; Yung, B.C.; Wang, G.; Liu, Y.; Ni, Q.; Zhang, F.; Zhou, Z.; Wang, J.; et al. Microneedle-Array Patches Loaded with Dual Mineralized Protein/Peptide Particles for Type 2 Diabetes Therapy. Nat. Commun. 2017, 8, 1777. [Google Scholar] [CrossRef] [PubMed]
  143. Yu, W.; Jiang, G.; Zhang, Y.; Liu, D.; Xu, B.; Zhou, J. Polymer Microneedles Fabricated from Alginate and Hyaluronate for Transdermal Delivery of Insulin. Mater. Sci. Eng. C 2017, 80, 187–196. [Google Scholar] [CrossRef] [PubMed]
  144. Moniz, T.; Costa Lima, S.A.; Reis, S. Marine Polymeric Microneedles for Transdermal Drug Delivery. Carbohydr. Polym. 2021, 266, 118098. [Google Scholar] [CrossRef]
  145. Moreira, A.F.; Rodrigues, C.F.; Jacinto, T.A.; Miguel, S.P.; Costa, E.C.; Correia, I.J. Poly (Vinyl Alcohol)/Chitosan Layer-by-Layer Microneedles for Cancer Chemo-Photothermal Therapy. Int. J. Pharm. 2020, 576, 118907. [Google Scholar] [CrossRef] [PubMed]
  146. Arshad, M.S.; Fatima, S.; Nazari, K.; Ali, R.; Farhan, M.; Muhammad, S.A.; Abbas, N.; Hussain, A.; Kucuk, I.; Chang, M.-W.; et al. Engineering and Characterisation of BCG-Loaded Polymeric Microneedles. J. Drug Target. 2020, 28, 525–532. [Google Scholar] [CrossRef]
  147. Li, Y.; Liu, F.; Su, C.; Yu, B.; Liu, D.; Chen, H.-J.; Lin, D.; Yang, C.; Zhou, L.; Wu, Q.; et al. Biodegradable Therapeutic Microneedle Patch for Rapid Antihypertensive Treatment. ACS Appl. Mater. Interfaces 2019, 11, 30575–30584. [Google Scholar] [CrossRef] [PubMed]
  148. Wang, Z.; Yang, Z.; Jiang, J.; Shi, Z.; Mao, Y.; Qin, N.; Tao, T.H. Silk Microneedle Patch Capable of On-Demand Multidrug Delivery to the Brain for Glioblastoma Treatment. Adv. Mater. 2022, 34, 2106606. [Google Scholar] [CrossRef] [PubMed]
  149. Zhang, X.; Chen, G.; Bian, F.; Cai, L.; Zhao, Y. Encoded Microneedle Arrays for Detection of Skin Interstitial Fluid Biomarkers. Adv. Mater. Deerfield Beach Fla 2019, 31, e1902825. [Google Scholar] [CrossRef] [PubMed]
  150. Sharma, S.; Huang, Z.; Rogers, M.; Boutelle, M.; Cass, A.E.G. Evaluation of a Minimally Invasive Glucose Biosensor for Continuous Tissue Monitoring. Anal. Bioanal. Chem. 2016, 408, 8427–8435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  151. Gao, J.; Huang, W.; Chen, Z.; Yi, C.; Jiang, L. Simultaneous Detection of Glucose, Uric Acid and Cholesterol Using Flexible Microneedle Electrode Array-Based Biosensor and Multi-Channel Portable Electrochemical Analyzer. Sens. Actuators B Chem. 2019, 287, 102–110. [Google Scholar] [CrossRef]
  152. Zhang, A.; Xiao, Z.; Liu, Q.; Li, P.; Xu, F.; Liu, J.; Tao, H.; Feng, L.; Song, S.; Liu, Z.; et al. CaCO3 -Encapuslated Microspheres for Enhanced Transhepatic Arterial Embolization Treatment of Hepatocellular Carcinoma. Adv. Healthc. Mater. 2021, 10, e2100748. [Google Scholar] [CrossRef] [PubMed]
  153. Jin, J.; Ji, Z.; Xu, M.; Liu, C.; Ye, X.; Zhang, W.; Li, S.; Wang, D.; Zhang, W.; Chen, J.; et al. Microspheres of Carboxymethyl Chitosan, Sodium Alginate, and Collagen as a Hemostatic Agent in Vivo. ACS Biomater. Sci. Eng. 2018, 4, 2541–2551. [Google Scholar] [CrossRef] [PubMed]
  154. Zhang, Y.; Jiang, G.; Yu, W.; Liu, D.; Xu, B. Microneedles Fabricated from Alginate and Maltose for Transdermal Delivery of Insulin on Diabetic Rats. Mater. Sci. Eng. C 2018, 85, 18–26. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The stylized conformational structure of sodium alginate, including G units, M units and their block patterns and linkages. G, α−L−guluronic acid residue; M, β−D−mannuronic acid residue. The common blocks of G and M units: GG blocks: homopolymer of G units; MM blocks: homopolymer of M units; GM or MG blocks: heteropolymer of G and M or M and G units.
Figure 1. The stylized conformational structure of sodium alginate, including G units, M units and their block patterns and linkages. G, α−L−guluronic acid residue; M, β−D−mannuronic acid residue. The common blocks of G and M units: GG blocks: homopolymer of G units; MM blocks: homopolymer of M units; GM or MG blocks: heteropolymer of G and M or M and G units.
Gels 08 00109 g001
Figure 2. The pattern chart of an egg-box structure.
Figure 2. The pattern chart of an egg-box structure.
Gels 08 00109 g002
Figure 3. Reaction formula of modified alginate to obtain its derivatives: (a) Acetylation of alginate using a mixture of pyridine/acetic anhydride. Gel acetylation: M = Ca2+ or TBA+. Acetylation of a homogeneous system in DMSO/TBAF, M = TBA+, M’ = −H or Na+; (b) Phosphorylation of alginates; (c) Sulfation of alginates. The alginate is sulfated with chlorosulfonic acid; (d) Oxidation of sodium alginate; (e) Reductive amination of oxidized sodium alginate.
Figure 3. Reaction formula of modified alginate to obtain its derivatives: (a) Acetylation of alginate using a mixture of pyridine/acetic anhydride. Gel acetylation: M = Ca2+ or TBA+. Acetylation of a homogeneous system in DMSO/TBAF, M = TBA+, M’ = −H or Na+; (b) Phosphorylation of alginates; (c) Sulfation of alginates. The alginate is sulfated with chlorosulfonic acid; (d) Oxidation of sodium alginate; (e) Reductive amination of oxidized sodium alginate.
Gels 08 00109 g003
Figure 4. Diagram of the coagulation process. Authorized by John Wiley and Sons Publications, copyright 2020 [80].
Figure 4. Diagram of the coagulation process. Authorized by John Wiley and Sons Publications, copyright 2020 [80].
Gels 08 00109 g004
Figure 5. The gel film layer formed by the hydrogel coating materials at the wound site. They can effectively absorb blood and body fluids, seal the wound, and maintain a suitable healing environment.
Figure 5. The gel film layer formed by the hydrogel coating materials at the wound site. They can effectively absorb blood and body fluids, seal the wound, and maintain a suitable healing environment.
Gels 08 00109 g005
Figure 6. The illustration exhibits how the hemostatic needles work through the coating. Their syringe needles are topically coated with cross-linking Alginate-CaCl2 hydrogel film coatings, which can swell to form hydrogels during puncture and play a significant role in preventing hemorrhage after puncture.
Figure 6. The illustration exhibits how the hemostatic needles work through the coating. Their syringe needles are topically coated with cross-linking Alginate-CaCl2 hydrogel film coatings, which can swell to form hydrogels during puncture and play a significant role in preventing hemorrhage after puncture.
Gels 08 00109 g006
Figure 7. The haemostatic capability of the Alg-Ca-coated needles in viscera puncture. (a) Photographs showing the haemostatic effect produced by Alg-Ca-coated needle (22 G) in rat kidney: bare needle (top) and Alg-Ca-coated needle (bottom). (b) Quantitative analysis of blood loss from rat kidney (n = 8, * p < 0.05) and liver (n = 8, ** p < 0.01). (c) Photographs showing the haemostatic effect of Alg-Ca-coated needle (22 G) in rat liver: bare needle (left) and Alg-Ca-coated needle (right). (d) Cytocompatibility evaluation of the Alg-Ca. [103] Copyright 2020 Elsevier Ltd.
Figure 7. The haemostatic capability of the Alg-Ca-coated needles in viscera puncture. (a) Photographs showing the haemostatic effect produced by Alg-Ca-coated needle (22 G) in rat kidney: bare needle (top) and Alg-Ca-coated needle (bottom). (b) Quantitative analysis of blood loss from rat kidney (n = 8, * p < 0.05) and liver (n = 8, ** p < 0.01). (c) Photographs showing the haemostatic effect of Alg-Ca-coated needle (22 G) in rat liver: bare needle (left) and Alg-Ca-coated needle (right). (d) Cytocompatibility evaluation of the Alg-Ca. [103] Copyright 2020 Elsevier Ltd.
Gels 08 00109 g007
Figure 8. The preparation and application process of TACMs.
Figure 8. The preparation and application process of TACMs.
Gels 08 00109 g008
Figure 9. Schematic diagram of the action of injectable hydrogels at the bleeding site. Injectable hydrogels in the form of solutions gel in situ at the wound site under certain conditions, recruit red blood cells and platelets, promote blood coagulation, and achieve the purpose of hemostasis.
Figure 9. Schematic diagram of the action of injectable hydrogels at the bleeding site. Injectable hydrogels in the form of solutions gel in situ at the wound site under certain conditions, recruit red blood cells and platelets, promote blood coagulation, and achieve the purpose of hemostasis.
Gels 08 00109 g009
Figure 10. (A) The chemistry behind the formation of Dopa-OA hydrogel glue. (B,C) The Dopa-OA hydrogel displayed higher tensile strength than OA glue. (D) Hemostatic performance of Dopa-OA glue with respect to OA glue and the control, when used in a mouse liver injury model. Reproduced with permission [128]. Copyright 2019, Springer Nature.
Figure 10. (A) The chemistry behind the formation of Dopa-OA hydrogel glue. (B,C) The Dopa-OA hydrogel displayed higher tensile strength than OA glue. (D) Hemostatic performance of Dopa-OA glue with respect to OA glue and the control, when used in a mouse liver injury model. Reproduced with permission [128]. Copyright 2019, Springer Nature.
Gels 08 00109 g010
Table 1. Preparation method of alginate hydrogels.
Table 1. Preparation method of alginate hydrogels.
Type of ReactionMaterialsMethods UsedForm of GelsPropertiesRef.
Ionic cross-linkingAlginate + ZnOCasting and solvent evaporationBi-layered hydrogel filmsAntibacterial properties, promotes healing capacity[58]
Ionic cross-linkingAlginate + shellacMicrofluidic technologyAmphiphilic hydrogel–solid dimer particlesAmphiphilic structure, biocompatibility[45]
Ionic cross-linkingAuNP-CaCO3 +
sodium alginate
/Hydrogel
precipitation
Fast response, pH-response, and ultrahigh sensitivity[59]
Electrostatic interaction and divalent chelationAlginate + N-carboxymethyl chitosan/Dual-crosslinked hydrogelsTunable mechanical properties, efficient wound closure[60]
Hydrogen bonds and Schiff cross-linkingOxidized sodium alginate + dopamine/HydrogelsSelf-healing, high tensile strength and stretchability[61]
Molecular entanglementsAlginate + carboxymethylcellulose sodium + chitosanThermoforming, high-speed blendingComposite hydrogelsWater vapor permeability[62]
Molecular entanglementsAlginate + PVA + PVPFreezing-thawing methodHydrogelsBioadhesive strength and mechanical properties[63]
Self-assembleAlginate + copolymer F127/HydrogelsThermo-responsive behavior[64]
Guest and host reactionPEG-Adamantane + β-CD + alginate/HydrogelsSelf-healing[65]
Photo-cross-linkingAlginate + PVP + chitosanGamma-radiationHydrogel padsPhotoreactivity, hygroscopicity[66]
Ionically cross-linking, covalent cross-linkinglaponite + PVA + alginate Nanohybrid hydrogelsBlood coagulation[67]
Covalent cross-linking, ionically cross-linkingOA + ECM + Amine-rGO Double-network hydrogelImproved mechanical properties and electrical conductivity[68]
Table 2. Summary of Different Types of Alginate Materials.
Table 2. Summary of Different Types of Alginate Materials.
TypeMaterialsActive IngredientsPropertiesIndicationsRef.
Fibrous dressingsAlginate + nZnOnZnOHigh porosity, antibacterial propertiesSevere bleeding and wounds at risk of infection[85]
Alginate + chitosan + hyaluronic acid/High swelling absorption propertiesMoist wound care[86]
Films and membranesSodium alginate (SA) + carboxymethyl chitosan (CMCH)Sr2+, Zn2+Cell adhesion enhancement and antibacterial propertiesVarious stages of wound healing[92]
Hyaluronic acid (HA) + sodium alginate (SA)Sulfadiazine, AgNPsMechanical property enhancement, antibacterial properties Local wound hemostasis and care[94]
Gel-ADH+ SA-mCHO/Rapid spray-filming performanceRapid and massive hemostasis[96]
SpongesSodium alginate (SA) + graphene oxide (GO) + polyvinyl alcohol (SPG)Norfloxacin (NFX)High water uptake and gas permeabilityHemostasis in superficial wounds, Wound dressings[99]
Oxidized cellulose nanocrystals (TOCN) + Sodium alginate (SA)/High chemical stability and water absorptionRapid local hemostasis[100]
Hm-alginate/High adhesivenessDressing for hemostasis[101]
Hemostatic needlesAlginate + CaCl2/Coating, hemostasis in situPrevention of bleeding after vascular and tissue puncture[103]
SA + HA + calcium carbonate CD34Coating, hemostasis in situStab wound hemostasis and healing[104]
SA + HA + calcium carbonate/Coating, hemostasis in situHemorrhage after AVF or AVG cannulation[105]
Embolic materialsAlginate + CaCl2·2H2O/Minimal trauma and good hemostatic effectHemostasis in solid visceral organ rupture and hemorrhage[121]
Alginate + CaCl2ThrombinEmbolic hemostasisParenchymal visceral hemorrhage[123]
CaCO3-Alginate/High safety and availabilityHepatocellular carcinoma therapy[152]
Injectable Hydrogels Pept-1 + ALGPept-1High mechanical strength and hemostatic efficiencyHemostasis in noncompressible wounds and irregular wounds[124]
Oxidized sodium alginate (OA) + dopamineDopamineHigh stiffness and elasticityHemostasis in deep tissue[126]
N-carboxyethyl chitosan + oxidized sodium alginateCuS-NPsInjectability and self-healingHemostasis of in situ wounds[130]
Hemostatic powdersCarboxymethyl chitosan + sodium alginate +
collagen
/High surface roughness and good biodegradabilityHemostasis in emergency conditions[153]
Alginate + silk fibroin/High surface roughnessRapid hemostasis in vitro and in vivo[132]
Alginate + collagen + TF liposomes Tissue factor (TF)Efficient and inexpensive, adaptation to various shapes of woundsRapid hemostasis in traumatic injury and deep wounds[79]
MicroneedlesAlginate + maltose + CaCl2InsulinExcellent mechanical strength and toughness, great swelling and dissolution propertiesSustained release transdermal delivery of insulin[154]
Sodium alginate + Bacillus Calmette–Guérin (BCG)Bacillus Calmette–Guérin (BCG)Small risk of inducing inflammatory response and skin damageTranscutaneous immunization with vaccine[146]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Xie, Y.; Gao, P.; He, F.; Zhang, C. Application of Alginate-Based Hydrogels in Hemostasis. Gels 2022, 8, 109. https://doi.org/10.3390/gels8020109

AMA Style

Xie Y, Gao P, He F, Zhang C. Application of Alginate-Based Hydrogels in Hemostasis. Gels. 2022; 8(2):109. https://doi.org/10.3390/gels8020109

Chicago/Turabian Style

Xie, Yue, Pan Gao, Fangfang He, and Chun Zhang. 2022. "Application of Alginate-Based Hydrogels in Hemostasis" Gels 8, no. 2: 109. https://doi.org/10.3390/gels8020109

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop